BRCA1 and neoplasm: In comparison to the NC group, the cisplatin treatment group exhibited smaller tumor size (Fig. 6D) and slightly lower expression of BRCA1, indicating that cisplatin (6 mg/kg) had drug effect to a limited extent, but the inhibitory effect on the growth of DDP-resistant cells in vivo was not as effective as in the combination group.